Category:NA-importance pharmacology pages
Appearance
This is a maintenance category, used for maintenance of the Wikipedia project. It is not part of the encyclopedia and contains non-article pages, or groups articles by status rather than subject. Do not include this category in content categories. |
Administrators: Please do not delete this category as empty! This category may be empty occasionally or even most of the time. |
Top | High | Mid | Low | NA | ??? |
121 | 883 | 3,149 | 6,650 | 1,638 | 3,542 |
Pages in category "NA-importance pharmacology pages"
The following 200 pages are in this category, out of approximately 1,638 total. This list may not reflect recent changes.
(previous page) (next page)B
- Talk:B-hydroxy b-methylbutyrate
- Talk:B-hydroxy-b-methylbutyrate
- Talk:B-Hydroxy-b-methylbutyrate
- Talk:B-hydroxy-b-methylbutyric acid
- Talk:B-Hydroxy-b-methylbutyric acid
- Talk:B-hydroxyisovalerate
- Talk:B-Hydroxyisovalerate
- Talk:B-hydroxyisovaleric acid
- Talk:B-Hydroxyisovaleric acid
- Talk:Bacteriostat
- Category talk:Bangladeshi COVID-19 vaccines
- Category talk:Bangladeshi pharmacologists
- Talk:Bango (cannabis)
- Category talk:Barbiturates
- Template talk:Barbiturates
- Category talk:Barbiturates-related deaths
- Talk:Barbourin
- Talk:Baseline (pharmacology)
- Category talk:Bayer
- File talk:BEAUTY-COMFORT By Madame Falloppe (1904).jpg
- Category talk:Behavioral addiction
- Talk:Behavioral pharmacology
- Category talk:Belgian pharmacologists
- Talk:Belmazol
- Talk:Beta Hydroxy beta methylbutyrate
- Category talk:Beta-adrenergic agonists
- Talk:Beta-hydroxy beta-methylbutyrate
- Talk:Beta-Hydroxy beta-methylbutyrate
- Talk:Beta-hydroxy beta-methylbutyric acid
- Talk:Beta-hydroxy-beta-methylbutyrate
- Talk:Beta-Hydroxy-beta-methylbutyrate
- Talk:Beta-Hydroxy-Beta-methylbutyrate
- Talk:Beta-hydroxy-beta-methylbutyrate free acid
- Talk:Beta-hydroxy-beta-methylbutyric acid
- Talk:Beta-Hydroxy-beta-methylbutyric acid
- Talk:Beta-Hydroxy-Beta-methylbutyric acid
- Talk:Beta-hydroxyisovalerate
- Talk:Beta-Hydroxyisovalerate
- Talk:Beta-hydroxyisovaleric acid
- Talk:Beta-Hydroxyisovaleric acid
- Talk:Beta-ketoamphetamine
- Category talk:Beta-lactamase inhibitors
- Talk:Betadine
- Talk:Betaglycan
- Talk:Betamethasone/calcipotriol
- Category talk:Bicalutamide
- Template talk:Bicalutamide
- Template talk:Bicalutamide metabolism
- Talk:Bicyclic antidepressant
- Template talk:Bile and liver therapy
- Category talk:Bio Farma
- Template talk:Biochemical parameters affected by estrogen therapy
- Category talk:Biochemistry
- Category talk:Biochemistry textbooks
- Category talk:Biology and pharmacology of chemical elements
- Category talk:Biopharmaceutical law firms
- File talk:Biosynthesis of cocaine.png
- File talk:Biosynthesis of N-methyl-pyrrolinium cation.png
- Category talk:Biotechnology
- Template talk:Birth control methods
- Talk:Blockbuster drug
- Category talk:Blood and blood forming organ drug stubs
- User talk:Bluerasberry/CenterWatch
- Talk:Board of Pharmacy
- Talk:Bonine
- File talk:Bottle for cocaine solution 2.jpg
- Talk:BPOM
- Talk:Brain disease model of addiction
- Talk:Brain PET
- Draft talk:Brandsymbol
- Category talk:Bristol Myers Squibb
- Category talk:British COVID-19 vaccines
- Category talk:British pharmacologists
- Talk:Broad-spectrum antivirals
- Category talk:Bronchodilators
- File talk:Bundesarchiv Bild 102-07741, Berlin, "Koks Emil" der Kokain-Verkäufer.jpg
- File talk:Burnett's Cocaine for the hair (advertisement, McClure's 1896).jpg
- Talk:Butanoic acid, 3-hydroxy-3-methyl-
C
- Talk:C29H53NO5
- Talk:CAB Abstracts Archive
- Category talk:Caffeine
- Talk:Caffeine tablets
- Talk:Calcium beta-hydroxy-beta-methylbutyrate
- Template talk:Calcium channel blockers
- Template talk:Calcium homeostasis
- Talk:Calcium hydroxymethylbutyrate
- Talk:Calcium polystyrene sulfonate
- Talk:Calcium β-hydroxy β-methylbutyrate
- Talk:Calcium β-hydroxy β-methylbutyrate monohydrate
- Talk:Calendula ointment
- Talk:Calpol
- Category talk:Canadian COVID-19 vaccines
- Category talk:Canadian pharmacologists
- Talk:Canasol
- Template talk:Cannabinoid receptor modulators
- Template talk:Cannabinoids
- Talk:Cannabis afghanica
- Talk:Cannabis use disorders
- Talk:Capadex
- Template talk:Cardiac glycosides
- Template talk:Cardiac stimulants excluding cardiac glycosides
- Template talk:Catecholamine and trace amine biosynthesis
- Category talk:Category-Class pharmacology pages
- Template talk:Cell wall disruptive antibiotics
- Template talk:CephalosporinAntiBiotics
- Talk:Cepi
- Talk:Ceprandal
- Draft talk:Cessatech
- Template talk:Channel blockers
- Template talk:Channel openers
- Template talk:Chelating agents
- Template talk:Chemical structures of equine estrogens
- Template talk:Chemical structures of major endogenous estrogens
- Template talk:Chemical structures of major endogenous estrogens medication version
- Template talk:Chemical-importance
- Category talk:Chemopreventive agents
- Category talk:Chemotherapeutic adjuvants
- Category talk:Chemotherapy regimens used in colorectal cancer
- Talk:Cheratussin
- Category talk:Chief executives in the pharmaceutical industry
- Category talk:Chinese COVID-19 vaccines
- Category talk:Chinese pharmacologists
- Talk:Chlorpheniramine and phenylpropanolamine
- Category talk:Chocolate
- Category talk:Choline esters
- Template talk:Chromalveolate antiparasitics
- Category talk:Clinical research
- Talk:Cloxacillin sodium
- Talk:CNTO 136
- Category talk:Coca in Bolivia
- Category talk:Cocaine
- File talk:Cocaine for kids.png
- File talk:Cocaine hydrochloride CII for medicinal use.jpg
- File talk:Cocaine lines 2.jpg
- File talk:Cocaine-from-xtal-1983-3D-balls.png
- File talk:CocaineCharango-Opened.jpg
- File talk:CocaineHCl.jpg
- File talk:CocaineHydrochloridePowder cropped.jpg
- Talk:Cognition enhancer
- Talk:Cognition enhancers
- Talk:Cognitive enhancer
- Talk:Cognitive enhancers
- Talk:Colofac
- Category talk:Combinatorial chemistry
- Category talk:Comics about drugs
- Talk:Comirnaty
- Talk:Commit Lozenge
- Category talk:Comparison of psychoactive substances
- Talk:Compassionate use
- Talk:Competitive antagonist
- Template talk:Components of opium
- Template talk:Composition of conjugated estrogens and properties of constituents
- Talk:Condylox
- Template talk:Contract research organization
- Template talk:Contrast media
- Category talk:Controlled substances in California
- Category talk:Controlled substances in Oregon
- Talk:Coronavir
- Template talk:Corticosteroids
- Talk:Cortodoxone
- Template talk:Cough and cold preparations
- Template talk:COVID-19 vaccine candidates
- Category talk:COVID-19 vaccines
- Category talk:COVID-19 vaccines by country
- Talk:CoviVac (disambiguation)
- Talk:Crisantaspase
- Talk:Crixivan
- Category talk:Croatian pharmacologists
- Draft talk:CT-996
- Category talk:Cuban COVID-19 vaccines
- Talk:CVS (store)
- Category talk:CVS Health
- Talk:Cyclic pyranopterin monophosphate
- Talk:Cyclopyrrone
- Template talk:Cyproterone acetate
- Talk:Cytomel
- Category talk:Czech pharmacologists
D
- File talk:D-glucose-chain-3D-balls.png
- Talk:D-tubocurare
- Talk:Daliresp
- Draft talk:Dan Berlau
- Category talk:Danish COVID-19 vaccines
- Category talk:Danish pharmacologists
- Talk:Danlox
- Talk:Deep Heat (heat rub)
- Category talk:Defunct pharmaceutical companies
- Category talk:Defunct pharmaceutical companies of Denmark
- Category talk:Defunct pharmaceutical companies of the United States
- Talk:Demeprazol
- Template talk:Demyelinating diseases of CNS
- Template talk:Dependence treatment
- Category talk:Deployment of COVID-19 vaccines
- Talk:Depon
- Template talk:Depressants
- Category talk:Dermatologic drugs
- Talk:Desec
- Talk:Desoxycorticosterone
- Category talk:Detoxification
- Template talk:Detoxifying agents for antineoplastic treatment
- Talk:Development of analogs of thalidomide